GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Clinical Transplantation, Wiley, Vol. 33, No. 10 ( 2019-10)
    Abstract: Despite significant advances in durable mechanical support survival, infectious complications remain the most common adverse event after ventricular assist device (VAD) implantation and the leading cause of early death after transplantation. In this study, we aim to describe our local infectious epidemiology and review short‐term survival and infectious incidence rates in the post‐transplantation period and assess risk factors for infectious episodes after transplantation. Methods Retrospective single‐center study of all consecutive adult heart transplant patients from 2008 to 2017. Survival data were estimated and summarized using the Kaplan‐Meier method. We quantified and evaluated the difference in the incidence rate between patients with and without infection using a Fine‐Gray model. The outcome of interest is the time to first infection diagnosis with post‐transplant death as the competing event. Results Among 278 heart transplant patients, 74 (26.5%) underwent LVAD implantation. Twenty‐one patients (28.3%) developed an infection while supported by an LVAD. When compared to patients supported by an LVAD without a preceding infection, BMI was significantly greater (31.2 vs 27.8 kg/m 2 , P  = .03). Median follow‐up post‐transplantation was 3.01 years. Significant risk factors for the competing risk regression for infection after heart transplantation include LVAD infection (HR 1.94, [95% CI] 1.11‐3.39, P  = .020) and recipient COPD (HR 2.14, [95% CI] 1.39‐3.32, P  = .001) when adjusted for recipient age, gender, hypertension, diabetes mellitus, and body mass index. Conclusions Patients with LVAD‐related infection had a significantly increased risk of infectious complications after heart transplantation. Further research on the avoidance of induction agents and reduced maintenance immunosuppression in this patient population is warranted.
    Type of Medium: Online Resource
    ISSN: 0902-0063 , 1399-0012
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2019
    detail.hit.zdb_id: 2739458-X
    detail.hit.zdb_id: 2004801-4
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Nutrition in Clinical Practice, Wiley, Vol. 37, No. 3 ( 2022-06), p. 677-697
    Abstract: Patients undergoing heart transplant (HT) and ventricular assist device (VAD) implant may experience intra‐ and postoperative complications requiring high‐dose vasopressor agents and/or mechanical circulatory support. These complications increase the risk of nonocclusive bowel ischemia (NOBI) and inadequate enteral nutrition (EN) delivery, and guidance for this high‐risk patient population is limited. To optimize nutrition support practices in this patient population at our institution, we created the High‐Risk Nutrition Support Protocol (HRNSP) to improve nutrient delivery and promote safer EN practices in the setting of NOBI risk factors after HT and VAD implant. Methods We developed and implemented a nutrition support protocol as a quality improvement (QI) initiative. Data were obtained before ( n  = 62) and after ( n  = 52) protocol initiation. We compared nutrition and clinical outcomes between the pre‐ and post‐intervention groups. Results Fewer calorie deficits ( P   〈  0.001), fewer protein deficits ( P   〈  0.001), a greater proportion of calorie/protein needs met ( P   〈  0.001), zero NOBI cases (0%), and decreased intensive care unit (ICU) length of stay (LOS) ( P  = 0.005) were observed with 100% ( n  = 52 of 54) HRNSP implementation success. Increased use of parenteral nutrition did not increase central line–associated bloodstream infections ( P  = 0.46). There was no difference in hospital LOS ( P  = 0.44) or 90‐day and 1‐year mortality ( P  = 0.56, P  = 0.35). Conclusion This single‐center, QI pre‐ and post‐protocol intervention outcome study suggests that implementing and adhering to a nutrition support protocol for VAD implant/HT patients with hemodynamic complications increases nutrient delivery and is associated with reduced ICU LOS and NOBI.
    Type of Medium: Online Resource
    ISSN: 0884-5336 , 1941-2452
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2022
    detail.hit.zdb_id: 2170063-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...